1. Home
  2. BDTX vs PET Comparison

BDTX vs PET Comparison

Compare BDTX & PET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • PET
  • Stock Information
  • Founded
  • BDTX 2014
  • PET 2015
  • Country
  • BDTX United States
  • PET United States
  • Employees
  • BDTX N/A
  • PET N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • PET EDP Services
  • Sector
  • BDTX Health Care
  • PET Technology
  • Exchange
  • BDTX Nasdaq
  • PET Nasdaq
  • Market Cap
  • BDTX 132.5M
  • PET 5.9M
  • IPO Year
  • BDTX 2020
  • PET N/A
  • Fundamental
  • Price
  • BDTX $2.41
  • PET $0.12
  • Analyst Decision
  • BDTX Strong Buy
  • PET Strong Buy
  • Analyst Count
  • BDTX 5
  • PET 3
  • Target Price
  • BDTX $15.60
  • PET $4.17
  • AVG Volume (30 Days)
  • BDTX 1.4M
  • PET 6.2M
  • Earning Date
  • BDTX 08-05-2025
  • PET 08-06-2025
  • Dividend Yield
  • BDTX N/A
  • PET N/A
  • EPS Growth
  • BDTX N/A
  • PET N/A
  • EPS
  • BDTX 0.09
  • PET N/A
  • Revenue
  • BDTX $70,000,000.00
  • PET $62,453,000.00
  • Revenue This Year
  • BDTX N/A
  • PET $7.87
  • Revenue Next Year
  • BDTX N/A
  • PET $122.23
  • P/E Ratio
  • BDTX $27.30
  • PET N/A
  • Revenue Growth
  • BDTX N/A
  • PET N/A
  • 52 Week Low
  • BDTX $1.20
  • PET $0.08
  • 52 Week High
  • BDTX $6.75
  • PET $1.69
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 57.88
  • PET 42.91
  • Support Level
  • BDTX $2.15
  • PET $0.09
  • Resistance Level
  • BDTX $2.71
  • PET $0.13
  • Average True Range (ATR)
  • BDTX 0.17
  • PET 0.01
  • MACD
  • BDTX -0.01
  • PET -0.00
  • Stochastic Oscillator
  • BDTX 55.36
  • PET 30.45

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About PET Wag! Group Co.

Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.

Share on Social Networks: